Population
Transgenic mice lacking wild-type dystrophin (mdx)
Comparison
Expression of dystrophin deleted for the… vs Mice with deletions in the central rod domain…
Design
Preclinical
Authors
Loading...
High-level truncated dystrophin mitigates mdx phenotype in mice; leaves open relevance for human DMD gene therapy or cardiomyopathy management.
An intact actin-binding domain in dystrophin is not strictly essential to prevent severe muscular dystrophy in mdx mice, provided the truncated protein is expressed at high levels.
Corrado et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: